St. Jude Persists In Effort To Correct The Record On Riata Study
This article was originally published in The Gray Sheet
Executive Summary
“We will continue to work through the proper channels with the HeartRhythm journal and the Heart Rhythm Society to ensure there is an appropriate presentation of validated, accurate information,” a company spokeswoman said.
You may also be interested in...
St. Jude Durata ICD Lead Insulation Breaches Probed In Hauser Study
MAUDE analysis suggests some trouble spots for St. Jude’s newer Optim-insulated ICD leads, according to researchers. But the company says the overall data shows the products to be as safe and reliable as competitors’ offerings.
Research In Brief
St. Jude Medical reports updated Riata defibrillator lead data. Alzheimer’s RNA-based blood test studies make progress. More research news.
Medical Device Market & Industry Briefs, April 2012
Brief summaries of recent medtech market and industry developments. This month we cover Covidien’s continuing buying spree, and other medtech M&A.